High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease
Clinical trial NCT01200329 · COMPLETED
Trial details
- NCT number
- NCT01200329
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2018-12-06
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.